In support of America's foreign policy, the U.S. Agency for International Development leads the U.S. Government's international development and disaster assistance through partnerships and investments that save lives, reduce poverty, strengthen democratic governance, and help people emerge from humanitarian crises and progress beyond assistance.
The Global Resilience Against Drug-Resistant Tuberculosis (GRAD-TB) program aims to support countries in improving the detection, treatment, and prevention of Drug-Resistant Tuberculosis (DR-TB) by developing and implementing innovative approaches and practices. This includes providing specialized technical assistance to local partners and National TB programs. The program seeks to help countries meet their commitments from the 2023 UN High-Level Meeting on TB, aligning with the WHO’s End TB Strategy and USAID’s Global TB Strategy for 2023-2030. It focuses on reducing the DR-TB burden through enhanced rapid detection, treatment, and prevention methods, while building sustainable, resilient systems that are equitable, inclusive, and accessible. The activity emphasizes the importance of utilizing local organizations and approaches and has identified specific countries within Africa, Asia, Eurasia, and Central Asia as its geographic focus, with others receiving technical support as indicated by USAID.